Unlike the conventionallmplantable Defibrillators which are implanted intravascular, the Subcutaneous lmplantableDefibrillators are inserted subcutaneously under the skin, and uses a subcutaneous electrode placed near the heart, rather than into the heart as in case of conventionallmplantable Defibrillators. A Subcutaneous lmplantable Defibrillator consists of a smalltitanium case which contains battery, a subcutaneous electrode, and accessories such asinsertion tool etc. If there is any abnormality in the patient's heartbeat, the subcutaneousimplantable defibrillator sends and electrical impulse to restore normalcy in the heartrhythm, followed by pacing therapy in form of post shock bradycardia, if needed.lmplantable defibrillators are useful in saving patients' lives with known history ofventricular tachycardia and arrhythmias.
This report contains market size and forecasts of Subcutaneous Implantable Cardioverter Defibrillator in global, including the following market information:
Global Subcutaneous Implantable Cardioverter Defibrillator Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Subcutaneous Implantable Cardioverter Defibrillator Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Subcutaneous Implantable Cardioverter Defibrillator companies in 2021 (%)
The global Subcutaneous Implantable Cardioverter Defibrillator market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ventricular Tachycardia Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Subcutaneous Implantable Cardioverter Defibrillator include Abbott, Koninklijke Philips, Nihon Kohden Corporation, Medtronic, Boston Scientific, MicroPort Scientific, ClearPoint Neuro, BIOTRONIK SE and ZOLL Medical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Subcutaneous Implantable Cardioverter Defibrillator manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Subcutaneous Implantable Cardioverter Defibrillator Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Implantable Cardioverter Defibrillator Market Segment Percentages, by Type, 2021 (%)
Ventricular Tachycardia
Hypertrophic Cardiomyopathy
Ventricular Dysplasia
Others
Global Subcutaneous Implantable Cardioverter Defibrillator Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Implantable Cardioverter Defibrillator Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Home Care
Global Subcutaneous Implantable Cardioverter Defibrillator Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Subcutaneous Implantable Cardioverter Defibrillator Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Subcutaneous Implantable Cardioverter Defibrillator revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Subcutaneous Implantable Cardioverter Defibrillator revenues share in global market, 2021 (%)
Key companies Subcutaneous Implantable Cardioverter Defibrillator sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Subcutaneous Implantable Cardioverter Defibrillator sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Koninklijke Philips
Nihon Kohden Corporation
Medtronic
Boston Scientific
MicroPort Scientific
ClearPoint Neuro
BIOTRONIK SE
ZOLL Medical